{
  "recommendations": [
    "CT Chest Angiography (CTA) for Pulmonary Embolism should be considered to evaluate for acute pulmonary embolism given the patient's symptoms of right-sided chest pain and presentation as an emergency.",
    "Given the patient's elevated creatinine (1.7 mg/dL) and moderate CKD (eGFR 59 mL/min/1.73m²), administer IV fluids pre- and post-contrast according to ACR guidelines to mitigate contrast-induced nephropathy risk.",
    "Monitor renal function post-imaging due to the potential risk of contrast-induced nephropathy."
  ],
  "rationale": [
    "Patient presents with right-sided chest pain, a common symptom of pulmonary embolism.",
    "eGFR of 59 mL/min/1.73m² indicates Stage 3a CKD, increasing risk of contrast-induced nephropathy.",
    "Hypotension (MAP 59 mmHg) further increases risk of contrast-induced nephropathy.",
    "CT Chest Angiography is the standard imaging modality for diagnosing pulmonary embolism.",
    "Hydration protocols are recommended by ACR for patients with renal insufficiency undergoing contrast-enhanced CT."
  ],
  "protocol_selection": [
    {
      "protocol_id": "CT_CHEST_ANGIO_PULMONARY_EMBOLISM",
      "name": "CT Pulmonary Angiography (Chest CTA for PE)",
      "indications": [
        "pulmonary embolism",
        "acute chest pain",
        "shortness of breath"
      ],
      "description": "CT angiography timed for pulmonary arterial phase (6–13 sec post-contrast) to evaluate pulmonary arteries for embolism.",
      "contrast_timing": "Pulmonary arterial phase: ≃6–13 sec post-injection.",
      "contrast_dose": "Weight-based; ~100–150 mL iodinated contrast (300 mg I/mL); follow ACR Manual.",
      "renal_safety_notes": "Ensure contrast-to-eGFR ratio <1.1 g/(mL/min); if eGFR <30, consider non-contrast alternatives or weigh risks carefully.",
      "references": [
        "Contrast CT phases overview (Wikipedia):contentReference[oaicite:0]{index=0}",
        "CT pulmonary angiogram practical notes (Wikipedia):contentReference[oaicite:1]{index=1}"
      ]
    }
  ]
}